Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064747304> ?p ?o ?g. }
- W2064747304 endingPage "175" @default.
- W2064747304 startingPage "166" @default.
- W2064747304 abstract "The successful clinical development of thalidomide, bortezomib, and lenalidomide not only transformed the therapeutic management of multiple myeloma (MM) but also catalyzed a renewed interest in the development of additional classes of novel agents for this disease. This review focuses on a series of new therapeutics that have shown promising preclinical results, as well as encouraging safety profiles and early evidence of anti-MM activity in clinical studies, either alone or in combination with other, conventional or novel, anti-MM treatments. These agents include second-generation proteasome inhibitors and immunomodulatory agents, as well as members of other therapeutic classes, such as histone deacetylase inhibitors (HDAC), heat shock protein 90 (Hsp90) inhibitors, and the alkylphospholipid Akt inhibitor perifosine." @default.
- W2064747304 created "2016-06-24" @default.
- W2064747304 creator A5006765393 @default.
- W2064747304 creator A5012712111 @default.
- W2064747304 creator A5030002291 @default.
- W2064747304 creator A5032464400 @default.
- W2064747304 creator A5043526996 @default.
- W2064747304 creator A5045740077 @default.
- W2064747304 creator A5049711954 @default.
- W2064747304 creator A5069524712 @default.
- W2064747304 creator A5091207345 @default.
- W2064747304 date "2009-04-01" @default.
- W2064747304 modified "2023-09-27" @default.
- W2064747304 title "Emerging Treatments for Multiple Myeloma: Beyond Immunomodulatory Drugs and Bortezomib" @default.
- W2064747304 cites W1519987732 @default.
- W2064747304 cites W1971948897 @default.
- W2064747304 cites W1975916512 @default.
- W2064747304 cites W1980471295 @default.
- W2064747304 cites W1980813154 @default.
- W2064747304 cites W1987583882 @default.
- W2064747304 cites W1998071923 @default.
- W2064747304 cites W2002125060 @default.
- W2064747304 cites W2004558311 @default.
- W2064747304 cites W2007998678 @default.
- W2064747304 cites W2010140285 @default.
- W2064747304 cites W2016742872 @default.
- W2064747304 cites W2016976719 @default.
- W2064747304 cites W2023814104 @default.
- W2064747304 cites W2024969918 @default.
- W2064747304 cites W2031284766 @default.
- W2064747304 cites W2047360780 @default.
- W2064747304 cites W2052169053 @default.
- W2064747304 cites W2066800926 @default.
- W2064747304 cites W2071115015 @default.
- W2064747304 cites W2072950603 @default.
- W2064747304 cites W2092537575 @default.
- W2064747304 cites W2099110265 @default.
- W2064747304 cites W2101127235 @default.
- W2064747304 cites W2103901963 @default.
- W2064747304 cites W2109635468 @default.
- W2064747304 cites W2117807601 @default.
- W2064747304 cites W2118335184 @default.
- W2064747304 cites W2119810076 @default.
- W2064747304 cites W2126267349 @default.
- W2064747304 cites W2129890171 @default.
- W2064747304 cites W2131612416 @default.
- W2064747304 cites W2133986577 @default.
- W2064747304 cites W2142149038 @default.
- W2064747304 cites W2147649894 @default.
- W2064747304 cites W2149386327 @default.
- W2064747304 cites W2150596051 @default.
- W2064747304 cites W2151445954 @default.
- W2064747304 cites W2156012049 @default.
- W2064747304 cites W2159831275 @default.
- W2064747304 cites W2162934657 @default.
- W2064747304 cites W2166427186 @default.
- W2064747304 cites W2169508075 @default.
- W2064747304 cites W2171513236 @default.
- W2064747304 cites W2499859474 @default.
- W2064747304 cites W2536202623 @default.
- W2064747304 cites W2555603866 @default.
- W2064747304 cites W2557075070 @default.
- W2064747304 cites W2565412611 @default.
- W2064747304 cites W2572099565 @default.
- W2064747304 cites W2577615809 @default.
- W2064747304 cites W2581029351 @default.
- W2064747304 cites W2584558360 @default.
- W2064747304 cites W2588637205 @default.
- W2064747304 cites W2592101711 @default.
- W2064747304 cites W2601932710 @default.
- W2064747304 cites W2917813256 @default.
- W2064747304 cites W2979432648 @default.
- W2064747304 cites W2979737561 @default.
- W2064747304 cites W2980939894 @default.
- W2064747304 cites W2982280349 @default.
- W2064747304 cites W2993774309 @default.
- W2064747304 cites W4230918129 @default.
- W2064747304 cites W4232496617 @default.
- W2064747304 doi "https://doi.org/10.1053/j.seminhematol.2009.02.003" @default.
- W2064747304 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2746942" @default.
- W2064747304 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19389500" @default.
- W2064747304 hasPublicationYear "2009" @default.
- W2064747304 type Work @default.
- W2064747304 sameAs 2064747304 @default.
- W2064747304 citedByCount "54" @default.
- W2064747304 countsByYear W20647473042012 @default.
- W2064747304 countsByYear W20647473042013 @default.
- W2064747304 countsByYear W20647473042014 @default.
- W2064747304 countsByYear W20647473042015 @default.
- W2064747304 countsByYear W20647473042016 @default.
- W2064747304 countsByYear W20647473042019 @default.
- W2064747304 countsByYear W20647473042020 @default.
- W2064747304 crossrefType "journal-article" @default.
- W2064747304 hasAuthorship W2064747304A5006765393 @default.
- W2064747304 hasAuthorship W2064747304A5012712111 @default.
- W2064747304 hasAuthorship W2064747304A5030002291 @default.
- W2064747304 hasAuthorship W2064747304A5032464400 @default.
- W2064747304 hasAuthorship W2064747304A5043526996 @default.